pd-l1 immunotherapy in bladder cancer
Published 9 years ago • 609 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
3:36
anti-pd-l1 immunotherapy with mpdl3280a in metastatic bladder cancer
-
1:32
utility of pd-l1 as a biomarker in bladder cancer
-
7:55
pd-l1 expression in bladder cancer
-
1:21
dr. o’donnell on pd-l1 testing in bladder cancer
-
1:12
dr. sharma on pd-l1 as biomarker for immunotherapy in bladder cancer
-
3:32
value of pd-l1 testing in metastatic urothelial cancer
-
5:14
treatment of bladder cancer-immune checkpoint inhibitors
-
1:30
dr. bellmunt on pd-l1 data in bladder cancer
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
6:03
pd-l1 expression in metastatic urothelial cancer
-
1:08
dr. balar on pd-l1 testing for urothelial cancer
-
0:52
dr. sonpavde on trials of immunotherapy in bladder cancer
-
1:47
dr. siefker-radtke on pd-l1 as a biomarker in bladder cancer
-
0:39
predicting immunotherapy response in bladder cancer
-
0:53
dr. sonpavde on immunotherapy plus chemotherapy in bladder cancer
-
5:50
ongoing immuno-oncology research in bladder cancer
-
3:48
pd-1 inhibitor use in kidney and bladder cancers
-
3:41
impact of immunotherapy in advanced bladder cancer
-
1:55
dr. grivas on investigational immunotherapy approaches in localized bladder cancer